XML 52 R29.htm IDEA: XBRL DOCUMENT v3.24.3
Note 1 - Nature of Operations (Details Textual)
$ / shares in Units, $ in Millions
 1 Months Ended 2 Months Ended 7 Months Ended 12 Months Ended
Oct. 04, 2024
USD ($)
shares
Nov. 02, 2022
USD ($)
shares
Oct. 31, 2024
USD ($)
$ / shares
shares
Oct. 31, 2023
USD ($)
Nov. 30, 2022
USD ($)
shares
Dec. 13, 2024
USD ($)
Sep. 30, 2023
USD ($)
$ / shares
shares
Sep. 30, 2024
USD ($)
$ / shares
Sep. 30, 2023
USD ($)
$ / shares
Aug. 31, 2024
USD ($)
Oct. 31, 2023
CAD ($)
Mar. 31, 2023
USD ($)
Sep. 30, 2022
$ / shares
Aug. 31, 2022
USD ($)
Feb. 28, 2021
CAD ($)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent               $ (6,198,010) $ (8,375,461)            
Retained Earnings (Accumulated Deficit)             $ 52,418,968 58,589,013 52,418,968            
Net Cash Provided by (Used in) Operating Activities               (4,890,205) (6,636,483)            
Cash and Cash Equivalents, at Carrying Value               1,000,000              
Working Capital (Deficit)               (200,000)              
Equity Offering, Maximum Amount                           $ 150,000,000  
Net Cash Provided by (Used in) Operating Activities               4,890,205 6,636,483            
Net Income (Loss) Attributable to Parent               6,170,045 $ 8,374,415            
Stock Issued During Period, Value, New Issues               $ 729,387              
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares             $ 19.51 $ 21.74 $ 19.51       $ 28    
Government Assistance, Nonoperating Income, Increase (Decrease)               $ 698,277 $ 581,039            
Revolving Credit Facility [Member] | Pardeep Nijhawan Medicine Professional Corporation [Member]                              
Line of Credit Facility, Maximum Borrowing Capacity       $ 10,000,000                      
Debt Instrument, Maturity Date               Mar. 31, 2026              
Debt Instrument, Covenant, Maximum Percentage of Borrowing Base for Outstanding Principal       85.00%             85.00%        
Unsecured Line of Credit [Member] | Pardeep Nijhawan Medicine Professional Corporation [Member]                              
Line of Credit Facility, Maximum Borrowing Capacity       $ 3,500,000                      
Line of Credit [Member] | Pardeep Nijhawan Medicine Professional Corporation [Member]                              
Debt Instrument, Basis Spread on Variable Rate       3.00%                      
The 2023 SIF Agreement [Member]                              
Government Assistance, Award Amount                     $ 23.0        
Government Assistance, Award Amount, Not Repayable                     5.8        
Government Assistance, Award Amount, Repyable                     $ 17.2        
Government Assistance, Nonoperating Income, Increase (Decrease)               $ 700,000 $ 600,000            
The 2021 SIF Agreement [Member]                              
Government Assistance, Award Amount                             $ 14.1
Twelve Month Warrants [Member]                              
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares         192,248                    
Three Year Warrants [Member]                              
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares         192,248                    
Canaccord [Member]                              
Equity Offering, Maximum Amount                   $ 20,000,000   $ 20,000,000      
Equity Offering, Limitation Amount                   $ 8,400,000   $ 8,400,000      
Stock Issued During Period, Value, New Issues             $ 700,000                
Stock Issued During Period, Shares, New Issues | shares             171,916                
Series A-1 Convertible Preferred Stock [Member]                              
Preferred Stock, Par or Stated Value Per Share | $ / shares     $ 10,000                        
Private Placement [Member]                              
Proceeds from Issuance or Sale of Equity   $ 2,900,000     $ 3,000,000                    
Stock Issued During Period, Value, New Issues   $ 2,700,000                          
Stock Issued During Period, Shares, New Issues | shares   384,475     384,475                    
Private Placement, Securities Purchase Agreement [Member] | Warrants to Purchase Common Shares [Member]                              
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares     326,560                        
Subsequent Event [Member] | Series A-1 Convertible Preferred Stock [Member]                              
Preferred Stock, Par or Stated Value Per Share | $ / shares     $ 10,000                        
Subsequent Event [Member] | Private Placement [Member] | Series A-1 Convertible Preferred Stock [Member]                              
Proceeds from Issuance or Sale of Equity           $ 1,500,000                  
Subsequent Event [Member] | At The Market Offering Agreement [Member]                              
Equity Offering, Maximum Amount $ 3,870,000   $ 3,870,000                        
Stock Issued During Period, Value, New Issues $ 600,000                            
Stock Issued During Period, Shares, New Issues | shares 220,269                            
Subsequent Event [Member] | Private Placement, Securities Purchase Agreement [Member]                              
Proceeds from Issuance or Sale of Equity     $ 1,540,819                        
Preferred Stock, Convertible, Conversion Ratio     0.75                        
Shares Issued, Price Per Share | $ / shares     $ 10,272.13                        
Subsequent Event [Member] | Private Placement, Securities Purchase Agreement [Member] | Warrants to Purchase Common Shares [Member]                              
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares     $ 3.445                        
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares     326,560                        
Warrants and Rights Outstanding, Term (Year)     5 years                        
Subsequent Event [Member] | Private Placement, Securities Purchase Agreement [Member] | Series A-1 Convertible Preferred Stock [Member]                              
Stock Issued During Period, Value, New Issues     $ 5,000,000                        
Stock Issued During Period, Shares, New Issues | shares     150                        
Subsequent Event [Member] | Private Placement, Securities Purchase Agreement [Member] | Series A-1 Convertible Preferred Stock [Member] | Conversion of Series A-1 Convertible Preferred Shares to Common Shares [Member]                              
Preferred Stock, Convertible, Shares Issuable | shares     2,903                        
Preferred Stock, Convertible, Conversion Price | $ / shares     $ 3.445                        
Convertible Preferred Stock, Shares Issued upon Conversion | shares     435,414